Redmile Group »

AgomAb Therapeutics NV shares owned by Redmile Group

Quarter-by-quarter ownership of AgomAb Therapeutics NV shares owned by Redmile Group from 13F filings

Historical chart of Redmile Group investment in AgomAb Therapeutics NV

Tip: Access up to 7 years of quarterly data

All positions including AgomAb Therapeutics NV held by Redmile Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AgomAb Therapeutics NV by Redmile Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.6M 156k 10.49

More positions owned by Redmile Group

Scholar Rock Hldg Corp (SRRK)
Krystal Biotech (KRYS)
Stoke Therapeutics (STOK)
Immunome (IMNM)
Nurix Therapeutics (NRIX)
Annexon (ANNX)
Adc Therapeutics Sa SHS (ADCT)
Regenxbio Inc equity us cm (RGNX)
Shattuck Labs (STTK)
Beam Therapeutics (BEAM)
Neurogene (NGNE)
Cogent Biosciences (COGT)
Absci Corp (ABSI)
Ideaya Biosciences (IDYA)
Alx Oncology Hldgs (ALXO)

View all positions for Redmile Group

Top funds holding AgomAb Therapeutics NV

Sanofi
Cormorant Asset Management
TCG Crossover Management
Federated Investors
Casdin Capital
Andera Partners
Nantahala Capital Management
Standard Life Aberdeen
Perceptive Advisors
Samsara BioCapital
LMR Partners
Seven Grand Managers
Redmile Group
Millennium Management
Alyeska Investment Group

View all funds holding AgomAb Therapeutics NV